As an expert explained in an interview with CURE, we may be in the midst of a “new era” for small cell lung cancer research.
The Food and Drug Administration (FDA) has approved Imfinzi (durvalumab) for adults with limited-stage small cell lung cancer ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results